DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy

Background:We analysed critically the potential usefulness of RNA- and DNA-based biomarkers in supporting conventional histological diagnostic tests for prostate carcinoma (PCa) detection.Methods:Microarray profiling of gene expression and DNA methylation was performed on 16 benign prostatic hyperplasia (BPH) and 32 cancerous and non-cancerous prostate samples extracted by radical prostatectomy. The predictive value of the selected biomarkers was validated by qPCR-based methods using tissue samples extracted from the 58 prostates and, separately, using 227 prostate core biopsies.Results:HOXC6, AMACR and PCA3 expression showed the best discrimination between PCa and BPH. All three genes were previously reported as the most promising mRNA-based markers for distinguishing cancerous lesions from benign prostate lesions; however, none were sufficiently sensitive and specific to meet the criteria for a PCa diagnostic biomarker. By contrast, DNA methylation levels of the APC, TACC2, RARB, DGKZ and HES5 promoter regions achieved high discriminating sensitivity and specificity, with area under the curve (AUCs) reaching 0.95−1.0. Only a small overlap was detected between the DNA methylation levels of PCa-positive and PCa-negative needle biopsies, with AUCs ranging between 0.854 and 0.899.Conclusions:DNA methylation-based biomarkers reflect the prostate malignancy and might be useful in supporting clinical decisions for suspected PCa following an initial negative prostate biopsy.

[1]  L. Goulart,et al.  Combined analysis of multiple mRNA markers by RT-PCR assay for prostate cancer diagnosis. , 2008, Clinical biochemistry.

[2]  Xavière Panhard,et al.  The 20-core prostate biopsy protocol--a new gold standard? , 2008, The Journal of urology.

[3]  Colleen D. McCabe,et al.  Genome-wide analysis of the homeobox C6 transcriptional network in prostate cancer. , 2008, Cancer research.

[4]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[5]  J. Didkowska,et al.  Nowotwory w Polsce w 2012 roku , 2013 .

[6]  Ishtiaq Rehman,et al.  Molecular Detection of Localized Prostate Cancer Using Quantitative Methylation-Specific PCR on Urinary Cells Obtained Following Prostate Massage , 2007, Clinical Cancer Research.

[7]  J. Witjes,et al.  Applicability of biomarkers in the early diagnosis of prostate cancer , 2004, Expert review of molecular diagnostics.

[8]  Anastasios Anastasiadis,et al.  Complications of prostate biopsy , 2013, Expert review of anticancer therapy.

[9]  S. Clark,et al.  Epigenetics in prostate cancer: biologic and clinical relevance. , 2011, European urology.

[10]  F. Montorsi,et al.  Initial extended transrectal prostate biopsy--are more prostate cancers detected with 18 cores than with 12 cores? , 2008, The Journal of urology.

[11]  Amit Patel,et al.  Prostate cancer detection with office based saturation biopsy in a repeat biopsy population. , 2004, The Journal of urology.

[12]  Lucila Ohno-Machado,et al.  The use of receiver operating characteristic curves in biomedical informatics , 2005, J. Biomed. Informatics.

[13]  S. Langley,et al.  Importance of HOX genes in normal prostate gland formation, prostate cancer development and its early detection , 2014, BJU international.

[14]  J. Lindberg,et al.  Identification of New Differentially Methylated Genes That Have Potential Functional Consequences in Prostate Cancer , 2012, PloS one.

[15]  K. D. Sørensen,et al.  Discovery of prostate cancer biomarkers by microarray gene expression profiling , 2010, Expert review of molecular diagnostics.

[16]  T. H. van der Kwast,et al.  Discovery of Novel Hypermethylated Genes in Prostate Cancer Using Genomic CpG Island Microarrays , 2009, PloS one.

[17]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[18]  J. Oesterling,et al.  A model for the number of cores per prostate biopsy based on patient age and prostate gland volume. , 1998, The Journal of urology.

[19]  D. Johnston,et al.  A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. , 2000, The Journal of urology.

[20]  Xiaowei Wang,et al.  PrimerBank: a PCR primer database for quantitative gene expression analysis, 2012 update , 2011, Nucleic Acids Res..

[21]  Krzysztof Goryca,et al.  Modeling Oncogenic Signaling in Colon Tumors by Multidirectional Analyses of Microarray Data Directed for Maximization of Analytical Reliability , 2010, PloS one.

[22]  E. Şerefoğlu,et al.  How reliable is 12-core prostate biopsy procedure in the detection of prostate cancer? , 2012, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[23]  E. Heath,et al.  Current Challenges in Development of Differentially Expressed and Prognostic Prostate Cancer Biomarkers , 2012, Prostate cancer.

[24]  S. Willard,et al.  Regulators of gene expression as biomarkers for prostate cancer. , 2012, American journal of cancer research.

[25]  F. Aragona,et al.  Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation. , 2007, Urology.

[26]  J. Anim,et al.  The role of combined measurement of tissue mRNA levels of AMACR and survivin in the diagnosis and risk stratification of patients with suspected prostate cancer , 2012, International Urology and Nephrology.

[27]  J. Schalken,et al.  The long and winding road to FDA approval of a novel prostate cancer test: our story. , 2013, Clinical chemistry.

[28]  U. Capitanio,et al.  Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy. , 2010, European urology.

[29]  Larissa V Furtado,et al.  Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer , 2011, BMC medicine.

[30]  Huey-Miin Hsueh,et al.  Biomarker selection for medical diagnosis using the partial area under the ROC curve , 2014, BMC Research Notes.

[31]  I. Thompson,et al.  Prostate rebiopsy is a poor surrogate of treatment efficacy in localized prostate cancer. , 1998, The Journal of urology.

[32]  Tanya K. Day,et al.  Common gene pathways and families altered by DNA methylation in breast and prostate cancers. , 2013, Endocrine-related cancer.

[33]  Z. Mo,et al.  APC gene hypermethylation and prostate cancer: a systematic review and meta-analysis , 2013, European Journal of Human Genetics.

[34]  M. Terris,et al.  Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. , 1989, The Journal of urology.

[35]  Wun-Jae Kim,et al.  EFEMP1 as a Novel DNA Methylation Marker for Prostate Cancer: Array-Based DNA Methylation and Expression Profiling , 2011, Clinical Cancer Research.

[36]  Wei Huang,et al.  Methylation profiling defines an extensive field defect in histologically normal prostate tissues associated with prostate cancer. , 2013, Neoplasia.

[37]  R Engers,et al.  Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylation , 2004, British Journal of Cancer.

[38]  Jacques Samarut,et al.  Differentially Expressed Androgen-Regulated Genes in Androgen-Sensitive Tissues Reveal Potential Biomarkers of Early Prostate Cancer , 2013, PloS one.

[39]  A. Jungwirth,et al.  Prostate cancer detection with two sets of ten-core compared with two sets of sextant biopsies. , 2001, Urology.

[40]  W. Schulz,et al.  DNA methylation changes in prostate cancer. , 2012, Methods in molecular biology.

[41]  Francesco Marabita,et al.  A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data , 2012, Bioinform..

[42]  P. McCue,et al.  Molecular diagnosis of prostate cancer: are we up to age? , 2013, Seminars in oncology.

[43]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[44]  Lee T. Sam,et al.  Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer. , 2011, Genome research.

[45]  V. Reuter,et al.  Benign mimics of prostatic adenocarcinoma on needle biopsy. , 1997, Anatomic pathology.

[46]  H. Ozen,et al.  Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection. , 2005, The Journal of urology.

[47]  Amit Patel,et al.  Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. , 2006, The Journal of urology.

[48]  W. Schulz,et al.  DNA Methylation and the HOXC6 Paradox in Prostate Cancer , 2011, Cancers.

[49]  M. Mikuła,et al.  Integrating proteomic and transcriptomic high-throughput surveys for search of new biomarkers of colon tumors , 2011, Functional & Integrative Genomics.